Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Reversal of gastric somatostatin receptor inhibition by Helicobacter pylori lipopolysaccharide with ebrotidine and sulglycotide.

Piotrowski J, Skrodzka D, Slomiany A, Slomiany BL.

Gen Pharmacol. 1997 May;28(5):705-8.

PMID:
9184806
2.

Helicobacter pylori lipopolysaccharide inhibition of gastric somatostatin receptor: effect of sucralfate.

Piotrowski J, Slomiany A, Slomiany BL.

Biochem Mol Biol Int. 1997 Jul;42(3):545-51.

PMID:
9247712
3.

Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal laminin receptor: effect of sulglycotide.

Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A, Slomiany BL.

Gen Pharmacol. 1993 Nov;24(6):1467-72.

PMID:
8112522
4.

Lipopolysaccharide a virulence factor of Helicobacter pylori: effect of antiulcer agents.

Piotrowski J.

J Physiol Pharmacol. 1998 Mar;49(1):3-24. Review.

PMID:
9594407
5.

Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.

Slomiany BL, Piotrowski J, Slomiany A.

Arzneimittelforschung. 1997 Apr;47(4A):475-82. Review.

PMID:
9205747
6.

Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal somatostatin receptor.

Piotrowski J, Majka J, Slomiany A, Slomiany BL.

Biochem Mol Biol Int. 1995 Jul;36(3):491-8.

PMID:
7549946
7.

Inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: effect of ebrotidine.

Slomiany BL, Piotrowski J, Murty VL, Slomiany A.

Gen Pharmacol. 1995 Nov;26(7):1553-8.

PMID:
8690245
8.

Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide: effect of sulglycotide.

Piotrowski J, Majka J, Murty VL, Czajkowski A, Slomiany A, Slomiany BL.

Gen Pharmacol. 1994 Sep;25(5):969-76.

PMID:
7835646
9.

Effect of ebrotidine on gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide.

Slomiany BL, Piotrowski J, Slomiany A.

J Physiol Pharmacol. 1999 Sep;50(3):391-404.

PMID:
10574469
10.

Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of ebrotidine.

Piotrowski J, Morita M, Slomiany A, Slomiany BL.

Biochem Int. 1992 Jun;27(1):131-8.

PMID:
1385705
11.

Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by sulglycotide.

Slomiany BL, Piotrowski J, Slomiany A.

Gen Pharmacol. 1999 Feb;32(2):251-7.

PMID:
10188628
12.

Gastroprotective agents in mucosal defense against Helicobacter pylori.

Slomiany BL, Murty VL, Piotrowski J, Slomiany A.

Gen Pharmacol. 1994 Sep;25(5):833-41. Review.

PMID:
7835626
13.
14.

Sucralfate counteracts the inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.

Slomiany A, Piotrowski J, Slomiany BL.

Scand J Gastroenterol Suppl. 1995;210:77-81.

PMID:
8578214
15.

Helicobacter pylori aggregating activity of gastric mucin with ulcer healing by ebrotidine.

Piotrowski J, Majka J, Piotrowski E, Murty VL, Gabryelewicz A, Slomiany A, Slomiany BL.

Biochem Mol Biol Int. 1994 Nov;34(5):875-81.

PMID:
7535617
16.

Ebrotidine effect on the proteolytic and lipolytic activities of Helicobacter pylori.

Slomiany BL, Piotrowski J, Mojtahed H, Slomiany A.

Gen Pharmacol. 1992 Mar;23(2):203-6.

PMID:
1639232
17.

Inhibition of Helicobacter pylori urease activity by ebrotidine.

Piotrowski J, Slomiany A, Slomiany BL.

Biochem Mol Biol Int. 1995 Oct;37(2):247-53.

PMID:
8673007
18.
19.

Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of nitecapone.

Slomiany BL, Piotrowski J, Rajiah G, Slomiany A.

Gen Pharmacol. 1991;22(6):1063-9.

PMID:
1839788
20.

Inhibition of Helicobacter pylori colonization by an antiulcer agent, sulglycotide.

Czajkowski A, Piotrowski J, Yotsumoto F, Slomiany A, Slomiany BL.

Biochem Mol Biol Int. 1993 Apr;29(5):965-71.

PMID:
8508147

Supplemental Content

Support Center